Scotia Capital’s Burcon NutraScience Corporation BRCN Stock Holding History

Scotia Capital’s Portfolio BRCN Stock Details BRCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-21,446	Closed	-$8K	–	847
2022 Q2	$8K	Buy	21,446 +528	+3%	+$342	﹤0.01%	803
2022 Q1	$19K	Sell	20,918 -55,945	-73%	-$54.7K	﹤0.01%	867
2021 Q4	$89K	Sell	76,863 -7,807	-9%	-$10.4K	﹤0.01%	844
2021 Q3	$132K	Sell	84,670 -259	-0.3%	-$603	﹤0.01%	815
2021 Q2	$236K	Buy	+84,929	New	+$272K	﹤0.01%	754

Other funds holding BRCN

FFG

Frisch Financial Group Melville, New York $478M AUM 16.28% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Scotia Capital's BRCN Position: Q3 2022 in Review

Scotia Capital sold out of Burcon NutraScience Corporation (BRCN) in Q3 2022, closing a stake of 21,446 shares — an estimated $8K sold.

Scotia Capital first reported a position in BRCN in Q2 2021 and held it in 5 quarters. The position peaked at $236K in Q2 2021. 2 funds tracked by Wall St. Rank hold BRCN as of Q3 2022.

Scotia Capital reported no remaining Burcon NutraScience Corporation position as of Q3 2022 after selling out during the quarter.
Scotia Capital sold 21,446 Burcon NutraScience Corporation shares in Q3 2022, an estimated $8K.
Scotia Capital first reported a position in Burcon NutraScience Corporation in Q2 2021 and held it in 5 quarters.
Scotia Capital's Burcon NutraScience Corporation position peaked at $236K in Q2 2021.
2 funds tracked by Wall St. Rank held Burcon NutraScience Corporation as of Q3 2022.

Based on Scotia Capital's 13F filing for Q3 2022, filed 10 Nov 2022.